FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367304538> ?p ?o ?g. }

• W4367304538 abstract "<h3>Objective:</h3> We report a case of <i>GNB1</i> encephalopathy arising from a <i>de novo</i> mutation in an uncommon locus presenting with a unique phenotype consisting of dystonia with myoclonus and vertical supranuclear gaze palsy (VSGP). <h3>Background:</h3> <i>GNB1</i> encephalopathy (OMIM: 616973), caused by pathogenic variants in the <i>GNB1</i> gene, is a rare neurodevelopmental syndrome variably co-occurring with movement disorders, with dystonia being the most frequently reported. Myoclonus occurring alongside dystonia and VGSP are uncommon findings. Most pathogenic variants occur in exons 6 and 7, which are considered to be mutational hotspots. <h3>Design/Methods:</h3> Not applicable. <h3>Results:</h3> This 27-year-old female presented with hypotonia and global developmental delay, intellectual disability, short stature, low body weight, dysarthria, a wide-based gait, and dystonia. She only had partial improvement with a trial of amantadine, and did not respond to dopaminergic therapy. In the ensuing years, she developed myoclonus, which persisted despite a gradual tapering off of amantadine. At 12 years of age, further examination disclosed a VSGP. Her axial dystonia, posture, and gait significantly improved with botulinum toxin (BoNTA) injections to the paraspinal muscles beginning at 18 years of age. Investigations including blood work, CSF neurotransmitters, imaging, and metabolic parameters were unrevealing. Electrophysiologic testing were consistent for both myoclonus superimposed on dystonia. Initial genetic investigations, which also included a proband whole exome sequencing (WES) were nondiagnostic. Updated trio WES six years after identified a <i>de novo</i>, heterozygous missense, likely pathogenic variant in the <i>GNB1</i> gene (c.1009A>C (p.Lys337Gln); exon 11). <h3>Conclusions:</h3> Our case illustrates the evolving clinical phenotypes of <i>GNB1</i> encephalopathy and highlights its importance as a diagnostic consideration for neurodevelopmental syndromes presenting with movement disorders and gaze abnormalities. In cases where the constellation of clinical findings suggests a genetic syndrome yet ascertainment of diagnosis is challenging, our experience highlights the value of repeating next-generation sequencing tests. <b>Disclosure:</b> Dr. Reyes has nothing to disclose. Dr. Garbin Di Luca has nothing to disclose. Dr. McNiven has nothing to disclose. Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions, Sun Pharma, Medichem, Medtronic, AbbVie and Sunovion. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received publishing royalties from a publication relating to health care." @default.
• W4367304538 created "2023-04-29" @default.
• W4367304538 creator A5008606741 @default.
• W4367304538 creator A5012450992 @default.
• W4367304538 creator A5025205823 @default.
• W4367304538 creator A5055369018 @default.
• W4367304538 date "2023-04-25" @default.
• W4367304538 modified "2023-10-17" @default.
• W4367304538 title "Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant (P11-11.008)" @default.
• W4367304538 doi "https://doi.org/10.1212/wnl.0000000000202621" @default.
• W4367304538 hasPublicationYear "2023" @default.
• W4367304538 type Work @default.
• W4367304538 citedByCount "0" @default.
• W4367304538 crossrefType "proceedings-article" @default.
• W4367304538 hasAuthorship W4367304538A5008606741 @default.
• W4367304538 hasAuthorship W4367304538A5012450992 @default.
• W4367304538 hasAuthorship W4367304538A5025205823 @default.
• W4367304538 hasAuthorship W4367304538A5055369018 @default.
• W4367304538 hasConcept C104317684 @default.
• W4367304538 hasConcept C118552586 @default.
• W4367304538 hasConcept C127716648 @default.
• W4367304538 hasConcept C15744967 @default.
• W4367304538 hasConcept C169760540 @default.
• W4367304538 hasConcept C187212893 @default.
• W4367304538 hasConcept C2776538686 @default.
• W4367304538 hasConcept C2778559928 @default.
• W4367304538 hasConcept C2779674439 @default.
• W4367304538 hasConcept C54355233 @default.
• W4367304538 hasConcept C71924100 @default.
• W4367304538 hasConcept C86803240 @default.
• W4367304538 hasConceptScore W4367304538C104317684 @default.
• W4367304538 hasConceptScore W4367304538C118552586 @default.
• W4367304538 hasConceptScore W4367304538C127716648 @default.
• W4367304538 hasConceptScore W4367304538C15744967 @default.
• W4367304538 hasConceptScore W4367304538C169760540 @default.
• W4367304538 hasConceptScore W4367304538C187212893 @default.
• W4367304538 hasConceptScore W4367304538C2776538686 @default.
• W4367304538 hasConceptScore W4367304538C2778559928 @default.
• W4367304538 hasConceptScore W4367304538C2779674439 @default.
• W4367304538 hasConceptScore W4367304538C54355233 @default.
• W4367304538 hasConceptScore W4367304538C71924100 @default.
• W4367304538 hasConceptScore W4367304538C86803240 @default.
• W4367304538 hasLocation W43673045381 @default.
• W4367304538 hasOpenAccess W4367304538 @default.
• W4367304538 hasPrimaryLocation W43673045381 @default.
• W4367304538 hasRelatedWork W2083599650 @default.
• W4367304538 hasRelatedWork W2128950897 @default.
• W4367304538 hasRelatedWork W2556569712 @default.
• W4367304538 hasRelatedWork W2804089674 @default.
• W4367304538 hasRelatedWork W2805862373 @default.
• W4367304538 hasRelatedWork W3015683500 @default.
• W4367304538 hasRelatedWork W3101156040 @default.
• W4367304538 hasRelatedWork W4214811733 @default.
• W4367304538 hasRelatedWork W4226096720 @default.
• W4367304538 hasRelatedWork W4313544974 @default.
• W4367304538 isParatext "false" @default.
• W4367304538 isRetracted "false" @default.
• W4367304538 workType "article" @default.